SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: rupers who wrote (856)4/5/2000 6:10:00 AM
From: AurumRabosa  Respond to of 1298
 
So, is Mr Market giving away CEGE's pipeline for free?
As of the close 4/4/00 CEGE had a mkt cap of $558.9 million while its cash and 12% ABGX stock was worth $591.4 million. Can we borrow from closed end fund jargon and say CEGE is selling at 5.5% discount to its NAV? Gotta tell myself something constructive while catching falling knives ;-)



To: rupers who wrote (856)4/5/2000 7:52:00 AM
From: mts362  Read Replies (1) | Respond to of 1298
 
Rupers-
I'm not looking at the 10-K, I'm saying that (in general) gains from investments are not given much credit from wall street -- that is a fact. This does improve the balance sheet (gives them a nice source of cash), but that's about it.

MTS


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News